We have been notified by Biogen that the production of the lyophilised form of Avonex (interferon beta-1a) BIO-SET which is used in the treatment of relapsing-remitting MS or clinically isolated syndrome, is being discontinued. This decision has been taken in view of the availability of alternative treatments and the diminishing market demand for the lyophilised form and is not due to any safety issues. This is the only presentation of Avonex that is being discontinued.
This week Declan Groeger juxtaposes two very different topics, MS and Irish history, to give a unique perspective. It is who walks alongside us that can transform loss to victory.
17th Annual General Meeting (56th AGM since MS Ireland’s foundation)
In the second of our year-long series of debate blogs, Trevis talks about NOT taking an MS disease modifying therapy'.
In this week’s MS & Me blog, Niamh takes a look at why she decided to go on medication to manage her MS.
Launch of EU wide Campaign to raise awareness of neurological conditions
© 2010 - 2024 Multiple Sclerosis Society of Ireland